These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23301036)

  • 1. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Claverie-Martín F; García-Nieto V; Loris C; Ariceta G; Nadal I; Espinosa L; Fernández-Maseda Á; Antón-Gamero M; Avila A; Madrid Á; González-Acosta H; Córdoba-Lanus E; Santos F; Gil-Calvo M; Espino M; García-Martinez E; Sanchez A; Muley R;
    PLoS One; 2013; 8(1):e53151. PubMed ID: 23301036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.
    Godron A; Harambat J; Boccio V; Mensire A; May A; Rigothier C; Couzi L; Barrou B; Godin M; Chauveau D; Faguer S; Vallet M; Cochat P; Eckart P; Guest G; Guigonis V; Houillier P; Blanchard A; Jeunemaitre X; Vargas-Poussou R
    Clin J Am Soc Nephrol; 2012 May; 7(5):801-9. PubMed ID: 22422540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype analysis of CLDN19 single nucleotide polymorphisms in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Martin-Nuñez E; Cordoba-Lanus E; Gonzalez-Acosta H; Oliet A; Izquierdo E; Claverie-Martin F
    World J Pediatr; 2015 Aug; 11(3):272-5. PubMed ID: 25410674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Perdomo-Ramirez A; Aguirre M; Davitaia T; Ariceta G; Ramos-Trujillo E; ; Claverie-Martin F
    Gene; 2019 Mar; 689():227-234. PubMed ID: 30576809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family.
    Yuan T; Pang Q; Xing X; Wang X; Li Y; Li J; Wu X; Li M; Wang O; Jiang Y; Dong J; Xia W
    Calcif Tissue Int; 2015 Apr; 96(4):265-73. PubMed ID: 25555744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset of chronic kidney disease: case report.
    Yamaguti PM; dos Santos PA; Leal BS; Santana VB; Mazzeu JF; Acevedo AC; Neves Fde A
    BMC Nephrol; 2015 Jul; 16():92. PubMed ID: 26136118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Vall-Palomar M; Madariaga L; Ariceta G
    Pediatr Nephrol; 2021 Oct; 36(10):3045-3055. PubMed ID: 33595712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease.
    Naeem M; Hussain S; Akhtar N
    Am J Nephrol; 2011; 34(3):241-8. PubMed ID: 21791920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    García-Castaño A; Perdomo-Ramirez A; Vall-Palomar M; Ramos-Trujillo E; Madariaga L; Ariceta G; Claverie-Martin F
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1475. PubMed ID: 32869508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: unusual clinical associations and novel claudin16 mutation in an Egyptian family.
    Al-Haggar M; Bakr A; Tajima T; Fujieda K; Hammad A; Soliman O; Darwish A; Al-Said A; Yahia S; Abdel-Hady D
    Clin Exp Nephrol; 2009 Aug; 13(4):288-294. PubMed ID: 19165416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomagnesemia-hypercalciuria-nephrocalcinosis and ocular findings: a new claudin-19 mutation.
    Ekinci Z; Karabaş L; Konrad M
    Turk J Pediatr; 2012; 54(2):168-70. PubMed ID: 22734304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin 19-based familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a sibling pair.
    Sharma S; Place E; Lord K; Leroy BP; Falk MJ; Pradhan M
    Clin Nephrol; 2016 Jun; 85(6):346-52. PubMed ID: 27007868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity is a common ground in familial hypomagnesemia with hypercalciuria and nephrocalcinosis caused by CLDN19 gene mutations.
    Vall-Palomar M; Burballa C; Claverie-Martín F; Meseguer A; Ariceta G
    J Nephrol; 2021 Dec; 34(6):2053-2062. PubMed ID: 33929692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene.
    Al-Shibli A; Konrad M; Altay W; Al Masri O; Al-Gazali L; Al Attrach I
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):338-44. PubMed ID: 23538362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations.
    Perdomo-Ramirez A; de Armas-Ortiz M; Ramos-Trujillo E; Suarez-Artiles L; Claverie-Martin F
    BMC Med Genet; 2019 Jan; 20(1):6. PubMed ID: 30621608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypomagnesaemia, Hypercalciuria and Nephrocalcinosis associated with a novel mutation of the highly conserved leucine residue 116 of Claudin 16 in a Chinese patient with a delayed diagnosis: a case report.
    Lu J; Zhao X; Paiardini A; Lang Y; Bottillo I; Shao L
    BMC Nephrol; 2018 Jul; 19(1):181. PubMed ID: 30005619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry.
    Arteaga ME; Hunziker W; Teo AS; Hillmer AM; Mutchinick OM
    Ren Fail; 2015 Feb; 37(1):180-3. PubMed ID: 25366522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.
    Faguer S; Chauveau D; Cintas P; Tack I; Cointault O; Rostaing L; Vargas-Poussou R; Ribes D
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):355-60. PubMed ID: 21030577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Konrad M; Hou J; Weber S; Dötsch J; Kari JA; Seeman T; Kuwertz-Bröking E; Peco-Antic A; Tasic V; Dittrich K; Alshaya HO; von Vigier RO; Gallati S; Goodenough DA; Schaller A
    J Am Soc Nephrol; 2008 Jan; 19(1):171-81. PubMed ID: 18003771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex.
    Hou J; Renigunta A; Konrad M; Gomes AS; Schneeberger EE; Paul DL; Waldegger S; Goodenough DA
    J Clin Invest; 2008 Feb; 118(2):619-28. PubMed ID: 18188451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.